Marvin L. White Sells 100,000 Shares of Aptevo Therapeutics Inc (APVO) Stock

Aptevo Therapeutics Inc (NASDAQ:APVO) insider Marvin L. White sold 100,000 shares of the stock in a transaction that occurred on Monday, March 19th. The stock was sold at an average price of $2.93, for a total value of $293,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

APVO stock opened at $3.05 on Friday. The company has a quick ratio of 5.08, a current ratio of 5.14 and a debt-to-equity ratio of 0.19. Aptevo Therapeutics Inc has a 1-year low of $1.15 and a 1-year high of $4.85.

How to Become a New Pot Stock Millionaire

A number of large investors have recently added to or reduced their stakes in the business. Acadian Asset Management LLC lifted its holdings in Aptevo Therapeutics by 87.2% during the 4th quarter. Acadian Asset Management LLC now owns 67,799 shares of the biotechnology company’s stock worth $287,000 after buying an additional 31,578 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in Aptevo Therapeutics by 8.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,056,729 shares of the biotechnology company’s stock worth $2,187,000 after buying an additional 78,109 shares during the last quarter. Virtu Financial LLC bought a new position in Aptevo Therapeutics during the 4th quarter worth approximately $690,000. Victory Capital Management Inc. bought a new position in Aptevo Therapeutics during the 4th quarter worth approximately $827,000. Finally, Renaissance Technologies LLC lifted its holdings in shares of Aptevo Therapeutics by 411.8% in the 4th quarter. Renaissance Technologies LLC now owns 428,400 shares of the biotechnology company’s stock worth $1,816,000 after purchasing an additional 344,700 shares during the last quarter. 33.04% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “Marvin L. White Sells 100,000 Shares of Aptevo Therapeutics Inc (APVO) Stock” was first published by Ticker Report and is owned by of Ticker Report. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/3296185/marvin-l-white-sells-100000-shares-of-aptevo-therapeutics-inc-apvo-stock.html.

Aptevo Therapeutics Company Profile

Aptevo Therapeutics Inc is a biotechnology company. The Company is focused on oncology and hematology therapeutics. The Company is engaged in the discovery, development, commercialization and sale of oncology and hematology therapeutics. The Company’s technology is the ADAPTIR (modular protein technology) platform.

Receive News & Ratings for Aptevo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptevo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

$3.95 Billion in Sales Expected for Kohl’s  This Quarter
$3.95 Billion in Sales Expected for Kohl’s This Quarter
$0.50 EPS Expected for Bitauto Hldg Ltd  This Quarter
$0.50 EPS Expected for Bitauto Hldg Ltd This Quarter
Inogen  Expected to Post Quarterly Sales of $62.60 Million
Inogen Expected to Post Quarterly Sales of $62.60 Million
Steem  Trading Up 13.1% Over Last Week
Steem Trading Up 13.1% Over Last Week
BitAsean  Market Capitalization Achieves $88,048.00
BitAsean Market Capitalization Achieves $88,048.00
C R Bard  Earns Coverage Optimism Rating of 0.16
C R Bard Earns Coverage Optimism Rating of 0.16


© 2006-2018 Ticker Report. Google+.